Literature DB >> 1767631

Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier.

F P Thomas1, W Trojaborg, C Nagy, M Santoro, S A Sadiq, N Latov, A P Hays.   

Abstract

Antibodies to GM1 or Gal(beta 1-3)GalNAc are associated with motor or sensorimotor neuropathy and with motor neuron disease. To investigate the role of these antibodies in the neurological disorder, rabbits were immunized with GM1 or with Gal(beta 1-3)GalNAc-BSA, and studied serologically, electrophysiologically and pathologically. Development of antibodies to the immunizing antigens was associated with a fall in the ratio of the amplitudes of the compound muscle action potential evoked by proximal versus distal stimulation of the sciatic nerve. Pathological studies revealed mild axonal degeneration and immunoglobulin deposits at the nodes of Ranvier in peripheral nerve, resembling those reported in a patient with motor neuropathy, motor conduction block and anti-GM1 antibodies. These studies provide evidence that anti-GM1 or anti-Gal(beta 1-3)GalNAc antibodies cause conduction abnormalities and indicate that the antibodies may exert their effect, in part, by binding at the nodes of Ranvier in peripheral nerve.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1767631     DOI: 10.1007/bf00296548

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  Specific modulation of sodium channels in mammalian nerve by monoclonal antibodies.

Authors:  H Meiri; E Goren; H Bergmann; I Zeitoun; Y Rosenthal; Y Palti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins.

Authors:  G Dighiero; P Lymberi; B Guilbert; T Ternynck; S Avrameas
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

3.  Changes in the sciatic nerve of the rabbit and its tissue constituents during development.

Authors:  A J Yates; J R Wherrett
Journal:  J Neurochem       Date:  1974-11       Impact factor: 5.372

4.  Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.

Authors:  F P Thomas; A M Lee; S N Romas; N Latov
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

5.  Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia.

Authors:  M E Shy; V A Evans; F D Lublin; R L Knobler; T Heiman-Patterson; A J Tahmoush; G Parry; P Schick; T G DeRyk
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

6.  Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

Authors:  Y Nagai; T Momoi; M Saito; E Mitsuzawa; S Ohtani
Journal:  Neurosci Lett       Date:  1976-04       Impact factor: 3.046

7.  Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly.

Authors:  N Spirman; B A Sela; C Gitler; E Calef; M Schwartz
Journal:  J Neuroimmunol       Date:  1984-06       Impact factor: 3.478

8.  A syndrome of asymmetric limb weakness with motor conduction block.

Authors:  C Krarup; J D Stewart; A J Sumner; A Pestronk; S A Lipton
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

9.  Peanut agglutinin receptor is a marker of myelin in rat brain. Developmental changes in its distribution.

Authors:  T Momoi; M Y Momoi; T Kurata
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

10.  Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.

Authors:  A Pestronk; V Chaudhry; E L Feldman; J W Griffin; D R Cornblath; E H Denys; M Glasberg; R W Kuncl; R K Olney; W C Yee
Journal:  Ann Neurol       Date:  1990-03       Impact factor: 10.422

View more
  14 in total

1.  Anti-GM1 antibodies in polyneuropathies of unknown origin.

Authors:  J Finsterer; W Muellbacher; W M Halbmayer; M Fischer; B Mamoli
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 2.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

Review 3.  Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview.

Authors:  K Ogawa-Goto; T Abe
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.

Authors:  J Zielasek; G Ritter; S Magi; H P Hartung; K V Toyka
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

5.  Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.

Authors:  C W Ang; M A De Klerk; H P Endtz; B C Jacobs; J D Laman; F G van der Meché; P A van Doorn
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in bovine spongiform encephalopathy.

Authors:  H Tiwana; C Wilson; J Pirt; W Cartmell; A Ebringer
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 7.  The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis.

Authors:  Pablo H H Lopez; Ricardo D Lardone; Fernando J Irazoqui; Mariana Maccioni; Gustavo A Nores
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

8.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

Authors:  J C Garcia-Monco; R J Seidman; J L Benach
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease.

Authors:  F P Thomas; C Chalk; R Lalonde; Y Robitaille; P Jolicoeur
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Lewis rats immunized with GM1 ganglioside do not develop peripheral neuropathy.

Authors:  Amjad A Ilyas; Zi-Wei Chen
Journal:  J Neuroimmunol       Date:  2007-06-07       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.